WASHINGTON, May 23 — COVID-19 Vaccine Warning from Moderna and Pfizer are under renewed scrutiny after the US Food and Drug Administration (FDA) directed the companies to add warning labels highlighting potential heart-related risks. This follows research published in the European Heart Journal indicating rare instances of myocarditis and pericarditis linked to mRNA vaccines. While the risks are minimal—affecting a small number out of thousands—the FDA aims to enhance informed consent amid rising COVID-19 concerns. India’s health authorities, meanwhile, assert that domestically used vaccines like Covishield and Covaxin remain safe, with no official guideline changes. Experts maintain that the benefits of vaccination outweigh the risks, which were largely rejected by WHO and ICMR following earlier controversy over heart attacks post-vaccination.
